News

  • Image for ADVANZ PHARMA to receive exclusive rights from Applied Therapeutics to commercialise AT-007 (govorestat) in Europe

    Press Releases —

    ADVANZ PHARMA to receive exclusive rights from Applied Therapeutics to commercialise AT-007 (govorestat) in Europe

    04 Jan 2023
    Learn more
  • Image for ADVANZ PHARMA further strengthens its specialty and hospital business by acquiring an anti-infective portfolio from Sanofi

    Press Releases —

    ADVANZ PHARMA further strengthens its specialty and hospital business by acquiring an anti-infective portfolio from Sanofi

    03 Oct 2022
    Learn more
  • Image for ADVANZ PHARMA to receive exclusive rights from PolyPid to commercialize D-PLEX100 in Europe

    Press Releases —

    ADVANZ PHARMA to receive exclusive rights from PolyPid to commercialize D-PLEX100 in Europe

    03 Aug 2022
    Learn more
  • Image for ADVANZ PHARMA completes acquisition of Intercept’s business in Europe, Canada, and all other markets outside of the U.S.

    Press Releases —

    ADVANZ PHARMA completes acquisition of Intercept’s business in Europe, Canada, and all other markets outside of the U.S.

    01 July 2022
    Learn more
  • Image for ADVANZ PHARMA to acquire Intercept’s business in Europe, Canada, and all other markets outside of the U.S.

    Press Releases —

    ADVANZ PHARMA to acquire Intercept’s business in Europe, Canada, and all other markets outside of the U.S.

    05 May 2022
    Learn more
  • Image for Steffen Wagner assumes his position as new Chief Executive Officer at ADVANZ PHARMA

    Press Releases —

    Steffen Wagner assumes his position as new Chief Executive Officer at ADVANZ PHARMA

    31 Mar 2022
    Learn more
  • Image for Cidron Aida Finco S.à r.l. Successful pricing of €175.0 million 5% Senior Secured Notes due 2028

    Press Releases —

    Cidron Aida Finco S.à r.l. Successful pricing of €175.0 million 5% Senior Secured Notes due 2028

    20 Jan 2022
    Learn more
  • Image for Cidron Aida Finco S.à r.l. Proposed Offering of €150 million 5% Senior Secured Notes due 2028

    Press Releases —

    Cidron Aida Finco S.à r.l. Proposed Offering of €150 million 5% Senior Secured Notes due 2028

    17 Jan 2022
    Learn more
Previous Page Next Page